Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 10/7/2025

Management of Hill Grade 2 Hiatus Hernia

Initial Medical Management

  • The American Gastroenterological Association recommends initiating a 4-8 week trial of single-dose PPI therapy taken 30-60 minutes before meals, combined with aggressive lifestyle modifications including weight management, head of bed elevation, and avoiding meals within 3 hours of bedtime for patients with Hill Grade 2 hiatus hernia 1, 2
  • Start any commercially available PPI as first-line therapy for 4-8 weeks, and instruct the patient to take the PPI 30-60 minutes before a meal for optimal efficacy 1, 2, 3
  • Reassess symptoms after the initial trial period, and if inadequate response, escalate to twice-daily dosing or switch to a more potent PPI (rabeprazole, esomeprazole, or dexlansoprazole) 1, 2
  • Once symptoms are controlled, taper to the lowest effective dose 1

Lifestyle Modifications

  • Elevate the head of the bed for patients with symptom burden following meals or during sleep, and avoid meals within 3 hours of bedtime to reduce supine reflux 1, 2
  • Aggressive weight management is recommended if overweight or obese, as central obesity exacerbates mechanical reflux 1, 3

Adjunctive Pharmacotherapy

  • Personalize adjunctive therapy based on the specific symptom phenotype, and consider alginate antacids (e.g., Gaviscon) for breakthrough symptoms, particularly useful in patients with known hiatus hernia for post-prandial and nighttime symptoms 4, 3
  • Nighttime H2 receptor antagonists may be used for nocturnal breakthrough symptoms, though limited by tachyphylaxis with chronic use 4, 3
  • Baclofen may be considered for regurgitation-predominant or belch-predominant symptoms, though CNS and GI side effects may limit use 4, 3

When to Pursue Further Evaluation

  • If symptoms persist despite optimized medical therapy, proceed with objective testing, including upper endoscopy to assess for erosive esophagitis and measure axial hiatus hernia length 1, 5, 6
  • Consider 96-hour wireless pH monitoring off PPI if endoscopy shows no erosive disease or long-segment Barrett's esophagus 5, 7

Surgical Considerations

  • Surgical intervention is reserved for patients with proven GERD who fail optimized medical therapy, and requires confirmatory evidence of pathologic GERD, exclusion of achalasia, and assessment of esophageal peristaltic function 5, 6
  • Effective surgical options include laparoscopic fundoplication, magnetic sphincter augmentation, and transoral incisionless fundoplication in carefully selected patients 5, 6
  • For obese patients with proven GERD, Roux-en-Y gastric bypass is an effective primary anti-reflux intervention 5, 6

Critical Pitfalls to Avoid

  • Do not continue long-term PPI without objective confirmation of GERD, and evaluate appropriateness within 12 months and consider endoscopy with pH monitoring 5, 8
  • Avoid metoclopramide as monotherapy or adjunctive therapy for GERD, and do not use opioids in patients with severe or refractory symptoms to minimize iatrogenic harm 3

Behavioral Interventions

  • Consider pharmacologic neuromodulation with low-dose tricyclic antidepressants for patients with esophageal hypervigilance, reflux hypersensitivity, or inadequate response to medical therapy 3
  • Refer to behavioral therapist for cognitive behavioral therapy, esophageal-directed hypnotherapy, or diaphragmatic breathing exercises 4, 6